SEHK:1530Biotechs
3SBio (SEHK:1530) Profit Margin Surges to 26%, Challenging Bearish Outlooks
3SBio (SEHK:1530) delivered standout numbers this past year, posting earnings growth of 42.2% year-over-year, which is significantly ahead of its 5-year average of 13.4% per year. Net profit margins have expanded to 26%, up from 19.7% last year. The recent share price of HK$30.86 sits well below the estimated fair value of HK$52.74. Investors are weighing this surge in profitability and attractive valuation against forecasts for an 11% annual decline in earnings and slower-than-market revenue...